There is a plethora of electrochemical biosensors developed for ultrasensitive detection of
clinically relevant biomarkers. However, many of these systems lose their performance in …

Nucleic acid aptamers are oligonucleotide chains with molecular recognition properties.
Compared with antibodies, aptamers show advantages given that they are readily produced …

Efficient and timely testing has taken center stage in the management, control, and
monitoring of the current COVID-19 pandemic. Simple, rapid, cost-effective diagnostics are …

Serological antigen testing has emerged as an important diagnostic paradigm in COVID-19,
but often suffers from potential cross-reactivity. To address this limitation, we herein report a …

The epidemic of infectious diseases caused by contagious pathogens is a life-threatening
hazard to the entire human population worldwide. A timely and accurate diagnosis is the …

The burden of incidence rate and mortality of cancer is increasing rapidly, and the
development of precise intervention measures for cancer detection and treatment will help …

Fast and accurate point-of-care testing (POCT) of infectious diseases is crucial for
diminishing the pandemic miseries. To fight the pandemic coronavirus disease 2019 …

The SARS‐CoV‐2 virus and COVID‐19 pandemic continue to demand effective diagnostic
and therapeutic solutions. Finding these solutions requires highly functional molecular …

During the COVID-19 pandemic, electrochemical biosensors have shown several
advantages including accuracy, low cost, possibility of miniaturization and portability, which …

A soluble isoform of cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) has been found
in the serum of healthy individuals and alterations in its expression level have been linked …